prestigio ring："对四种抗逆转录病毒药物均有抗药性并希望简化治疗的 80 岁男性艾滋病毒感染者"。

IF 1.5 4区医学 Q4 MICROBIOLOGY New Microbiologica Pub Date : 2024-01-01

Maria Mazzitelli, Maurizio Zazzi, Giulia Marchetti, Vincenzo Spagnuolo, Maria Mercedes Santoro, Emanuele Focà, Annamaria Cattelan, Antonella Castagna

{"title":"prestigio ring：\"对四种抗逆转录病毒药物均有抗药性并希望简化治疗的 80 岁男性艾滋病毒感染者\"。","authors":"Maria Mazzitelli, Maurizio Zazzi, Giulia Marchetti, Vincenzo Spagnuolo, Maria Mercedes Santoro, Emanuele Focà, Annamaria Cattelan, Antonella Castagna","doi":"","DOIUrl":null,"url":null,"abstract":"People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"46 4","pages":"407-411"},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PRESTIGIO RING: \\\"An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification\\\".\",\"authors\":\"Maria Mazzitelli, Maurizio Zazzi, Giulia Marchetti, Vincenzo Spagnuolo, Maria Mercedes Santoro, Emanuele Focà, Annamaria Cattelan, Antonella Castagna\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.\",\"PeriodicalId\":54723,\"journal\":{\"name\":\"New Microbiologica\",\"volume\":\"46 4\",\"pages\":\"407-411\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"New Microbiologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Microbiologica","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

对 4 种抗逆转录病毒类药物耐药的艾滋病患者是一个非常具有挑战性的群体。他们很难制定完全抑制的治疗方案，而且合并症和多重用药的高发病率可能会导致药物间的相互作用，并危及服药的依从性。我们在此介绍一位参与 PRESTIGIO 登记的 80 岁男性患者的病例，他要求减轻抗逆转录病毒药物的负担，同时因合并症而使用多种药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

PRESTIGIO RING: "An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification".

People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

New Microbiologica 生物-微生物学

CiteScore

2.20

自引率

5.60%

发文量

审稿时长

6-12 weeks

期刊介绍： The publication, diffusion and furtherance of research and study on all aspects of basic and clinical Microbiology and related fields are the chief aims of the journal.